Alur Orthopedic Implants
Alur Orthopedic Implants
Year Founded
Exp. Countries
Top-tier Hospitals
IP Certificates
Global Agents
The United States remains the global epicentre for orthopedic innovation, particularly in the field of Total Knee Replacement (TKR). As the American population ages—with the "Baby Boomer" generation reaching retirement—the demand for high-quality joint arthroplasty has skyrocketed. Current market analysis suggests that by 2030, the number of primary total knee replacements in the U.S. is projected to grow by 673%, reaching nearly 3.5 million procedures annually.
As a leading TKR manufacturer and exporter, we leverage the advanced industrial infrastructure of the United States. The shift from traditional hospital settings to Ambulatory Surgery Centers (ASCs) has redefined product requirements. Today’s orthopedic surgeons demand instrumentation kits that are not only precise but also optimized for rapid sterilization and outpatient efficiency. Our production capacity covers more than 8,000 product specifications, ensuring that we meet the rigorous standards of the FDA and the high expectations of American medical professionals.
The "Blue Ocean" strategy we employ focuses on three critical pillars: Robotic Assistance, Material Science, and Patient-Specific Implants (PSI).
From the world-renowned orthopedic centers in New York and Rochester to the burgeoning healthcare hubs in Texas and Florida, our products are designed for diverse clinical environments:
The company's self-operated export business is taking shape, leveraging the prestige of U.S. engineering. While our core market remains the domestic healthcare system, our sales are extending rapidly to countries such as Brazil, Colombia, Peru, Egypt, and Morocco. We provide comprehensive technical support and academic promotion to our 300+ agents worldwide, ensuring that the same quality of care found in top-tier U.S. hospitals is accessible globally.
Our commitment to R&D is evidenced by our 27 national utility model patent certificates, 6 invention patents, and 2 software copyrights. We focus specifically on limb orthopedics and internal fixation products. This focus strategy allows us to maintain a competitive advantage in quality control and manufacturing precision, ensuring every TKR component we produce meets the highest safety profile for the patient.
The company places great importance on scientific and technological innovation, as well as new product research and development. Its product development strategy follows the principles of "blue ocean, differentiation, and focus strategy," with a strong emphasis on limb orthopedics, pediatric orthopedics, and internal and external fixation products for foot and ankle surgery. The company has obtained 27 national utility model patent certificates, 6 invention patents, and 2 software copyrights.
With a production capacity covering more than 8,000 product specifications in orthopedic trauma, spinal implants, and surgical instruments, the company has gradually established competitive advantages in research and development, production and manufacturing, quality control, marketing, and other key areas.
The marketing team consists of more than 40 professionals, with sales and technical service personnel present in over 20 major cities. The company has built a nationwide marketing network covering 31 provinces and cities, collaborating with more than 300 agents and serving over 300 top-tier teaching hospitals. It actively engages in academic promotion, technical services, and product training, participating in or hosting more than 50 academic conferences for orthopedic doctors annually.
